pubmed-article:16950028 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:16950028 | lifeskim:mentions | umls-concept:C0030797 | lld:lifeskim |
pubmed-article:16950028 | lifeskim:mentions | umls-concept:C0442043 | lld:lifeskim |
pubmed-article:16950028 | lifeskim:mentions | umls-concept:C0029435 | lld:lifeskim |
pubmed-article:16950028 | lifeskim:mentions | umls-concept:C0449258 | lld:lifeskim |
pubmed-article:16950028 | lifeskim:mentions | umls-concept:C0040508 | lld:lifeskim |
pubmed-article:16950028 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:16950028 | pubmed:dateCreated | 2006-9-4 | lld:pubmed |
pubmed-article:16950028 | pubmed:abstractText | This study examined the natural progression of pelvic osteolysis post uncemented total hip arthroplasty. Serial radiographs from 145 total hip arthroplasties with minimum 10-year follow-up were examined. Thirty-two lesions were identified in 25 hips and their 2-dimensional radiographic size over time was measured via computer. Lesion growth rate averaged 42.7 +/- 49.0 mm2/y. Linear models were generally a good fit for lesion growth as evidenced by a high mean r2 value (0.77 +/- 0.18); lesions progressed steadily during the first 10 postoperative years. Although lesions were first radiographically evident 5.7 years postarthroplasty, the x-intercept of the linear model, approximating the mean time when the lesions first began to develop, averaged 1.3 years. Because this study expands our understanding of when and how peri-acetabular lesions develop, it can be useful to clinicians in determining how often to see patients postoperatively. | lld:pubmed |
pubmed-article:16950028 | pubmed:language | eng | lld:pubmed |
pubmed-article:16950028 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16950028 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:16950028 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16950028 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:16950028 | pubmed:month | Sep | lld:pubmed |
pubmed-article:16950028 | pubmed:issn | 0883-5403 | lld:pubmed |
pubmed-article:16950028 | pubmed:author | pubmed-author:EnghCharles... | lld:pubmed |
pubmed-article:16950028 | pubmed:author | pubmed-author:KitamuraNobut... | lld:pubmed |
pubmed-article:16950028 | pubmed:author | pubmed-author:Sychterz-Tere... | lld:pubmed |
pubmed-article:16950028 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:16950028 | pubmed:volume | 21 | lld:pubmed |
pubmed-article:16950028 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:16950028 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:16950028 | pubmed:pagination | 791-5 | lld:pubmed |
pubmed-article:16950028 | pubmed:meshHeading | pubmed-meshheading:16950028... | lld:pubmed |
pubmed-article:16950028 | pubmed:meshHeading | pubmed-meshheading:16950028... | lld:pubmed |
pubmed-article:16950028 | pubmed:meshHeading | pubmed-meshheading:16950028... | lld:pubmed |
pubmed-article:16950028 | pubmed:meshHeading | pubmed-meshheading:16950028... | lld:pubmed |
pubmed-article:16950028 | pubmed:meshHeading | pubmed-meshheading:16950028... | lld:pubmed |
pubmed-article:16950028 | pubmed:meshHeading | pubmed-meshheading:16950028... | lld:pubmed |
pubmed-article:16950028 | pubmed:meshHeading | pubmed-meshheading:16950028... | lld:pubmed |
pubmed-article:16950028 | pubmed:meshHeading | pubmed-meshheading:16950028... | lld:pubmed |
pubmed-article:16950028 | pubmed:meshHeading | pubmed-meshheading:16950028... | lld:pubmed |
pubmed-article:16950028 | pubmed:meshHeading | pubmed-meshheading:16950028... | lld:pubmed |
pubmed-article:16950028 | pubmed:meshHeading | pubmed-meshheading:16950028... | lld:pubmed |
pubmed-article:16950028 | pubmed:meshHeading | pubmed-meshheading:16950028... | lld:pubmed |
pubmed-article:16950028 | pubmed:meshHeading | pubmed-meshheading:16950028... | lld:pubmed |
pubmed-article:16950028 | pubmed:meshHeading | pubmed-meshheading:16950028... | lld:pubmed |
pubmed-article:16950028 | pubmed:year | 2006 | lld:pubmed |
pubmed-article:16950028 | pubmed:articleTitle | The temporal progression of pelvic osteolysis after uncemented total hip arthroplasty. | lld:pubmed |
pubmed-article:16950028 | pubmed:affiliation | Anderson Orthopaedic Research Institute, Alexandria, Virginia 22307, USA. | lld:pubmed |
pubmed-article:16950028 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:16950028 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |